Pentwater Capital Management LP Pure Tech Health PLC Transaction History
Pentwater Capital Management LP
- $7.74 Billion
- Q2 2024
A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 16,193 shares of PRTC stock, worth $337,462. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,193
Previous 17,000
4.75%
Holding current value
$337,462
Previous $484,000
16.53%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PRTC
# of Institutions
6Shares Held
20.1KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY2.83KShares$58,9140.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX700Shares$14,5880.0% of portfolio
-
Ubs Group Ag351Shares$7,3140.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY73Shares$1,5210.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $581M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...